Invitae Corporation (NVTAQ) operates as a medical genetics enterprise, striving to advance healthcare outcomes by furnishing crucial genetic information to individuals across the United States, Canada, and other international markets. The company's diverse offerings include genetic diagnostic services for various clinical domains, such as hereditary cancer risk assessment, targeted oncology, women's health concerns, rare medical conditions, and pharmacogenomics (the study of how genes affect a person's response to drugs). Additionally, Invitae delivers innovative digital health solutions and comprehensive health data management services.